The Patent Finder

Heart Metabolics Limited

Also on record
Records under this name other than patents Heart Metabolics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Heart Metabolics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,470,806Perhexiline for treating chronic heart failure
Lapsed on the fee record
Ended Jun 25, 2021 · USPTO record
Lapsed on the fee recordEnded Jun 25, 2021USPTO record
US 8,440,697Treatment of heart failure
Lapsed on the fee record
Ended May 14, 2021 · USPTO record
Lapsed on the fee recordEnded May 14, 2021USPTO record
US 9,468,634Treatment of heart failure
Lapsed on the fee record
Ended Oct 18, 2020 · USPTO record
Lapsed on the fee recordEnded Oct 18, 2020USPTO record
US 9,457,017Treatment of heart failure
Lapsed on the fee record
Ended Oct 4, 2020 · USPTO record
Lapsed on the fee recordEnded Oct 4, 2020USPTO record
US 8,697,677Perhexiline for treating chronic heart failure
Lapsed on the fee record
Ended Apr 15, 2018 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2018USPTO record
US 8,697,728Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM)
Lapsed on the fee record
Ended Apr 15, 2018 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited